July 31, 2019
2 min watch
Save

VIDEO: Review finds visual improvements in anti-VEGF for diabetic retinopathy

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

CHICAGO — At the American Society of Retina Specialists meeting, Rishi P. Singh, MD, of the Cole Eye Institute at the Cleveland Clinic, discusses a retrospective review of the VISTA and VIVID studies looking at visual improvements in patients receiving anti-VEGF treatment for diabetic retinopathy.